James Maitland is a leading figure in health economics, known for his incisive analysis of how legislative frameworks shift the financial landscape of American medicine. With years of experience tracking the intersection of policy and provider behavior, Maitland has become a vital voice for those trying to understand the ripple effects of the No Surprises Act. Since the law’s implementation, he has closely monitored the tension between insurers and medical groups, specifically how the resolution of out-of-network billing has veered away from initial government projections. In this discussion, we explore the recent calls for more research from the Congressional Budget Office and the growing concerns that a law designed to save consumers money might actually be fueling a new era of healthcare inflation. The conversation touches upon the overwhelming volume of legal disputes, the unexpected success rates of providers in arbitration, and the long-term consequences for insurance premiums and the national deficit.
When the No Surprises Act was first drafted, the Congressional Budget Office projected a manageable 17,000 arbitration cases per year, yet we are seeing numbers that completely dwarf those estimates. What happened to create such a massive surge in legal disputes?
The reality on the ground has shattered those early expectations with a force that few in Washington anticipated. In just the first half of 2025, we saw providers file a staggering 1.2 million disputes, a volume that has turned a designed safety valve into a high-speed assembly line of litigation. This “snowballing” of cases is largely driven by a concentrated group of private equity-backed medical companies that have realized the Independent Dispute Resolution process can be utilized as a primary revenue strategy. Instead of seeing arbitration as a last resort, these entities are using it as a high-stakes lever to bypass traditional network agreements. The administrative weight of handling over a million cases in six months has created a backlog that threatens to overwhelm the system’s intended function of quick, fair resolution.
The data suggests that providers are winning these disputes more than eight out of ten times and securing payouts far above standard rates. How is this lopsided victory rate changing the power dynamic between doctors and insurance companies?
The current statistics are a major red flag for anyone concerned about healthcare spending, as providers are currently winning 88% of all surprise billing disputes. It is not just the frequency of the wins that is alarming, but the scale of the awards, which are often coming in at three or four times the comparable in-network rates. When a doctor or a medical group realizes they can consistently secure triple or quadruple the payment through an arbiter than they could through a negotiated contract, the incentive to stay in an insurance network virtually vanishes. This creates a “lopsided” advantage where the provider has all the leverage to demand higher rates, knowing that the alternative—arbitration—is likely to be even more lucrative. We are seeing a dramatic shift where the “middlemen” in this dispute process are becoming the architects of a new, much higher price floor for medical services.
In 2021, the CBO estimated that this law would lower reimbursement rates and eventually decrease monthly premiums for consumers, but now they are sounding the alarm. Why has the agency’s outlook shifted so dramatically?
The CBO is essentially admitting that their initial models did not account for the aggressive “gaming” of the system by certain provider groups. Back in 2021, the hope was that by shielding patients from out-of-network bills, the law would force providers to accept lower, more reasonable rates. However, emerging evidence suggests the opposite is happening because the Independent Dispute Resolution process has become a backdoor for “price gouging” rather than a path toward affordability. The agency is now deeply concerned that if providers can systematically secure these massive payouts, it will lead to higher negotiated prices across the entire market over the long term. This isn’t just a theoretical problem; the CBO notes that even though these disputes represent fewer than 0.05% of all claims, their outsized impact on bargaining can drive up premiums and eventually widen federal deficits.
Insurer groups and advocacy organizations are calling for “commonsense guardrails” to stop what they describe as provider-driven abuse. What specific reforms or policy actions could actually rebalance this system without leaving patients vulnerable again?
The call for reform is growing louder because the current trend lines are pointing toward a law that acts as a deficit-increaser rather than a reducer. Insurer groups like AHIP are pushing for a total overhaul of the Independent Dispute Resolution process to address the flawed incentives that currently favor private equity-backed providers. One immediate focus is the implementation of stricter regulations to prevent “ineligible” disputes from clogging up the system, a move that health officials have recently begun to finalize. However, many experts argue that we need more than just administrative tweaks; we need a mechanism that prevents arbiters from awarding payments that are wildly out of sync with established in-network benchmarks. Without these guardrails, the law risks becoming a permanent engine for wasteful spending that ultimately gets passed down to the consumer in the form of higher monthly costs.
What is your forecast for the No Surprises Act?
My forecast is that the No Surprises Act will undergo a period of intense legislative or regulatory revision as the financial data becomes too significant for Congress to ignore. While the law has been undeniably successful in its primary goal—protecting patients from the shock of a massive, unexpected medical bill—the secondary effect of driving up systemic costs is a ticking time bomb. I expect to see a move toward more standardized “benchmark” payments that limit the ability of arbiters to grant those 300% or 400% payouts above in-network rates. We are already seeing the CBO and various advocacy groups laying the groundwork for this shift, and as the 1.2 million dispute figure continues to climb, the pressure to “stop the abuse” will eventually force a bipartisan re-evaluation of the IDR process. Ultimately, the system must be recalibrated so that it protects the patient’s wallet without inadvertently emptying the public coffers through inflated provider reimbursements.
